No abstract available
Publication types
-
Clinical Trial, Phase I
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / pharmacokinetics
-
Bevacizumab / administration & dosage*
-
Bevacizumab / pharmacokinetics
-
Diabetic Retinopathy / complications
-
Diabetic Retinopathy / drug therapy*
-
Diabetic Retinopathy / metabolism
-
Female
-
Humans
-
Macula Lutea / pathology*
-
Macular Edema / drug therapy*
-
Macular Edema / etiology
-
Macular Edema / metabolism
-
Male
-
Plasma Kallikrein / antagonists & inhibitors
-
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
-
Tomography, Optical Coherence / methods
-
Treatment Outcome
-
Visual Acuity*
Substances
-
Angiogenesis Inhibitors
-
Bevacizumab
-
Receptors, Vascular Endothelial Growth Factor
-
Plasma Kallikrein